PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.19%
Positive revenue growth while 1113.HK is negative. John Neff might see a notable competitive edge here.
-16.23%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1724.67%
Negative EBIT growth while 1113.HK is at 2.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
2.41%
Operating income growth under 50% of 1113.HK's 6.94%. Michael Burry would be concerned about deeper cost or sales issues.
-2395.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2389.16%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2389.16%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.16%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.16%
Slight or no buyback while 1113.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
27.59%
OCF growth under 50% of 1113.HK's 159.60%. Michael Burry might suspect questionable revenue recognition or rising costs.
20.17%
FCF growth under 50% of 1113.HK's 507.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-33.59%
Negative 10Y revenue/share CAGR while 1113.HK stands at 226.02%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
64142.86%
5Y revenue/share CAGR above 1.5x 1113.HK's 165.89%. David Dodd would look for consistent product or market expansions fueling outperformance.
815.52%
3Y revenue/share CAGR above 1.5x 1113.HK's 14.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-121.97%
Negative 10Y OCF/share CAGR while 1113.HK stands at 726.46%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-20.09%
Negative 5Y OCF/share CAGR while 1113.HK is at 60.36%. Joel Greenblatt would question the firm’s operational model or cost structure.
22.17%
Positive 3Y OCF/share CAGR while 1113.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-217.80%
Negative 10Y net income/share CAGR while 1113.HK is at 85.30%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-29.05%
Negative 5Y net income/share CAGR while 1113.HK is 180.70%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-22.71%
Negative 3Y CAGR while 1113.HK is 83.32%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-47.75%
Negative 5Y equity/share growth while 1113.HK is at 1303.81%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.24%
Negative 3Y equity/share growth while 1113.HK is at 30.63%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.73%
We show growth while 1113.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
11.49%
Asset growth above 1.5x 1113.HK's 0.13%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-7.74%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
390.08%
Debt growth far above 1113.HK's 4.81%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
306.60%
We expand SG&A while 1113.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.